Medical weight loss
Prescription Options
Compare GLP-1 injections, oral GLP-1 pills and established non-GLP-1 choices.
Browse prescriptionsW8MD Weight Loss, Sleep & Medspa
Weight Loss Prescriptions With a Medical Plan Behind Them
Compare FDA-approved GLP-1 injections, new weight loss pills and established prescription options with experienced W8MD clinicians serving Brooklyn, New York City and Greater Philadelphia.
- Personalized prescription and health-history review
- Insurance-friendly visits and transparent self-pay pathways
- Nutrition, sleep-apnea screening and long-term maintenance
Your plan. Your progress.Physician-supervised prescriptions, nutrition, sleep care and long-term maintenance
20+ yearsPhysician experience
Modern choicesInjections and tablets
Two active officesBrooklyn and Philadelphia
Long-term careMaintenance, not a quick fix
W8MDMedical care
More than medication
The Right Prescription Starts With the Right Evaluation
Weight gain is rarely caused by one issue. Appetite signaling, insulin resistance, sleep apnea, medications, stress, hormonal changes, nutrition, activity and genetics may all matter. W8MD evaluates the full picture before recommending treatment.
Medical screening
Review current conditions, medications, contraindications, vital signs, BMI and laboratory needs.
Personalized options
Compare benefits, risks, administration, insurance coverage, price and treatment preferences.
Sleep health
Screen for snoring, fatigue and obesity-related sleep apnea; arrange home sleep testing when appropriate.
Maintenance
Build nutrition, protein, activity, follow-up and relapse-prevention strategies around treatment.
One coordinated program
Weight Loss, Sleep and Wellness—Connected
Prescription treatment works best when nutrition, metabolic health, sleep and long-term habits are addressed together.
Sleep medicine
Sleep Apnea Care
Connect snoring, fatigue and obesity-related sleep risk with testing and treatment.
Explore sleep care
Long-term support
Results and Maintenance
See individual patient experiences and learn why ongoing maintenance matters.
Read success storiesUpdated for 2026
FDA-Approved Weight Loss Prescriptions
New oral options have expanded the field beyond weekly injections. These summaries are educational; prescription treatment requires individual medical evaluation.
Foundayo® (orforglipron)
FDA-approved in 2026 for long-term weight reduction in eligible adults. It is a nonpeptide GLP-1 receptor agonist taken as a tablet.
Foundayo guideWegovy® tablets
Oral semaglutide is approved for weight reduction in eligible adults. It must be taken on an empty stomach according to prescribing instructions.
Wegovy pill guideWegovy® injection
Semaglutide injection is approved for chronic weight management; a higher adult dose expanded available treatment choices in 2026.
Wegovy guideZepbound® (tirzepatide)
Approved for chronic weight management in eligible adults and for moderate-to-severe obstructive sleep apnea in adults with obesity.
Tirzepatide guideSaxenda® (liraglutide)
A daily injectable option for chronic weight management in eligible adults and certain adolescents.
Liraglutide guideQsymia®, Contrave® & orlistat
Established non-GLP-1 choices may suit selected patients after screening for cardiovascular, pregnancy, seizure, opioid-use and other considerations.
Compare medications| Prescription | Form | Primary role | Learn more |
|---|---|---|---|
| Foundayo (orforglipron) | Daily tablet | Long-term weight reduction in eligible adults | Foundayo |
| Wegovy (semaglutide) | Daily tablet or weekly injection | Chronic weight management; additional indications depend on formulation and eligibility | Wegovy |
| Zepbound (tirzepatide) | Weekly injection | Chronic weight management; obesity-related OSA in eligible adults | Zepbound |
| Saxenda (liraglutide) | Daily injection | Chronic weight management in eligible adults and adolescents | Saxenda |
| Qsymia / Contrave / Xenical | Oral | Non-GLP-1 long-term options for selected patients | Overview |
| Phentermine | Oral | Short-term prescription option for selected patients | Phentermine |
Brand-name distinction: Ozempic® and Mounjaro® are diabetes medications and are not FDA-approved specifically for weight loss. Their active ingredients are used in the weight-management brands Wegovy® and Zepbound®. Imcivree® is reserved for certain rare genetic forms of obesity. Do not combine GLP-1 medicines unless specifically directed by a qualified prescriber.
W8MD special offers
Affordable GLP-1 Starting-Dose Pathways
Talk with W8MD about clinical eligibility, insurance coverage, FDA-approved brands and other available pathways.
Semaglutide-based program
Weekly GLP-1 support
$29.99+ / week with qualifying insured visits*
Self-pay starting-dose programs may begin at $59.99 per week and up for eligible patients.
- Medical eligibility assessment
- Dose and side-effect monitoring
- Nutrition and maintenance planning
Tirzepatide-based program
Dual GIP/GLP-1 support
$45+ / week with qualifying insured visits*
Self-pay starting-dose programs may begin at $69.99 per week and up for eligible patients.
- Zepbound coverage review when appropriate
- Sleep-apnea screening when indicated
- Individualized follow-up and maintenance
*Published starting-dose promotional pricing for eligible patients. Prices vary by dose, medication source, pharmacy, visit type, insurance, shipping, laboratory needs and program requirements. Insurance coverage for a medical visit does not guarantee medication coverage. Compounded medications are not FDA-approved.
How W8MD works
From First Visit to Long-Term Maintenance
Schedule
Choose Brooklyn, Northeast Philadelphia or eligible telehealth and tell us what type of care interests you.
Evaluate
A clinician reviews your history, current medicines, goals, vital signs, safety factors, labs when needed, coverage and budget.
Treat & maintain
If treatment is appropriate, W8MD combines monitoring, dose adjustments, nutrition, activity, sleep care and maintenance planning.
Patient experience
Support That Continues Beyond the First Prescription
W8MD’s goal is not simply to prescribe medication. Follow-up care helps patients manage side effects, navigate plateaus, protect nutrition and plan for long-term weight maintenance.
★★★★★
“Fantastic program! Truly a life changer! The first several months I lost on average 3 pounds a week. I have now lost 87 pounds in 10 months and I’m still losing.”
D.M. — W8MD patient story
One patient’s experience; results and rates of weight loss vary. No outcome is guaranteed.
Active W8MD offices
Weight Loss Doctors in Brooklyn and Philadelphia
Serving eligible patients across NYC, New Jersey, Connecticut, Pennsylvania and Delaware through active offices and legally appropriate telehealth.
Greater Philadelphia
Northeast Philadelphia, PA
1718 Welsh Road, 2nd Floor, Suite C
Philadelphia, PA 19115
Trusted W8MD resources
Learn More From the W8MD Network
Continue with medication guides, local weight loss information, sleep medicine, medical aesthetics, recipes and patient education.
Weight Loss Prescriptions Blog
Internal articles about prescription medications, diets, insurance and healthy weight loss.
W8MD.com Medication Guides
Detailed GLP-1, semaglutide, tirzepatide, Wegovy, Zepbound and Foundayo information.
NYC Medical Weight Loss
Brooklyn and New York City GLP-1 programs, local education and appointment information.
Philadelphia Medical Weight Loss
Greater Philadelphia prescription weight loss, GLP-1 care and local resources.
W8MD Weight Loss, Sleep & Medspa
Explore integrated medical weight loss, sleep medicine and medical aesthetic services.
W8MD.org Weight Loss Options
Compare lifestyle treatment, GLP-1 programs, traditional prescriptions and maintenance.
Common questions
Weight Loss Prescription FAQ
These general answers cannot determine which medication is safe or appropriate for you.
Explore all medicationsWhich FDA-approved weight loss prescription works best?
There is no single best medication for everyone. Selection depends on medical history, BMI, related conditions, contraindications, pregnancy plans, current drugs, desired administration, insurance, price and response to prior treatment.
Are oral GLP-1 weight loss pills now available?
Yes. Wegovy tablets containing semaglutide were approved for weight reduction in adults, and Foundayo containing orforglipron became a newly approved oral GLP-1 option in 2026. Each has specific dosing and safety instructions.
Does W8MD accept insurance?
W8MD accepts many insurance plans for qualifying medical visits. Medication coverage is separate and depends on the plan’s formulary, exclusions, deductible, copay and prior-authorization requirements.
Are compounded GLP-1 medicines FDA-approved?
No. Compounded medications do not undergo FDA premarket review for safety, quality and effectiveness and are not the same as FDA-approved brand-name products. Availability and legal requirements can change.
Can W8MD help with sleep apnea?
Yes. W8MD can screen for obstructive sleep apnea, arrange home sleep testing when appropriate and discuss PAP therapy and weight management. Zepbound has an FDA-approved indication for moderate-to-severe OSA in adults with obesity who meet the prescribing criteria.